跳至主要内容
临床试验/NCT04487197
NCT04487197已完成不适用

SARS-CoV2 (COVID-19) Seroepidemiological Investigation in Transplanted Population Subjects of Kidney, Kidney-pancreas, Isolated Pancreas, Langerhans Islets

Antonio Secchi1 个研究点 分布在 1 个国家目标入组 282 人开始时间: 2020年7月15日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
282
试验地点
1
主要终点
Serum-prevalence of COVID-19 TX

研究概览

简要总结

Evaluate SARS-CoV2 infection and the degree of immunity possibly developed in transplanted population using the Luciferase Immuno Precipitation System (LIPS) test.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

结局指标

主要结局

Serum-prevalence of COVID-19 TX

时间窗: From 15 July 2020 to 15 January 2021

Evaluation of serum-prevalence data transplanted patients (symptomatic vs asymptomatic patients)

Serum-prevalence of COVID-19 / Age, Gender, Type of transplantation, comorbities, Italian regions-proviences transplanted patients

时间窗: From 15 July 2020 to 15 January 2021

Correlation serum-prevalence of COVID-19 / Age, Gender, Type of transplantation, comorbities, Italian regions-proviences transplanted patients

次要结局

  • Risk factors for infection COVID-19 transplanted patients(From 15 July 2020 to 15 January 2021)
  • Hospitalization rate COVID-19 transplanted patients(From 15 July 2020 to 15 January 2021)
  • Asymptomatic or subclinical infections in transplanted patients(From 15 July 2020 to 15 January 2021)
  • Mortality rate COVID-19 transplanted patients(From 15 July 2020 to 15 January 2021)

研究者

发起方
Antonio Secchi
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Antonio Secchi

MD

IRCCS San Raffaele

研究点 (1)

Loading locations...

相似试验